 CAMBRIDGE, Mass., Feb. 10, 2022 GLOBE NEWSWIRE -- Voyager Therapeutics, Inc. Nasdaq: VYGR a gene therapy company developing life-changing treatments and next-generation adeno-associated virus AAV technologies, today announced that it will participate in the following virtual investor conferences. 